InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Barlow Carrolee, Director. Director active across 1 company, notably Supernus Pharmaceuticals, INC.. Cumulatively, 5 filings have been recorded. Activity tracked since 19 February 2022. The latest transaction was disclosed on 24 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
5 of 5 declarations
Carrolee Barlow is a Director at Supernus Pharmaceuticals, Inc. She participates in the governance of the company and contributes to strategic decision-making. Her role is essential to ensure compliance and the smooth operation of the company's activities.